Chemotherapy in epithelial ovarian cancer

descriptionPublicationkeyboard_double_arrow_right Article 28 Apr 2011 English Publisher:Elsevier BVJournal:Cancer Letters, volume 303, pages 73-83 (issn: 0304-3835,

Copyright policy )

Authors: Sandro, Pignata; Lucia, Cannella; Davide, Leopardo; Carmela, Pisano; Giovanni Salvatore, Bruni; Gaetano, Facchini;

doi: 10.1016/j.canlet.2011.01.026

pmid: 21353386

Chemotherapy in epithelial ovarian cancer

- Summary
- Subjects
- Metrics

Abstract

Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation.

Keywords

Ovarian Neoplasms, Clinical Trials as Topic, Antineoplastic Agents, Middle Aged, Medical Oncology, Prognosis, Treatment Outcome, Drug Therapy, Recurrence, Humans, Female, Aged

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	89
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%